Pfizer Inc $28.92

up +0.10


22/8/2014 04:00 PM  |  NYSE : PFE  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get PFE Trend Analysis - it has underperformed the S&P 500 by 17%

Partner Headlines

  1. Nasdaq Leads Mixed Session; Actavis Extends Gains

    IBD
  2. Contract Researcher Parexel Sees Growth In Biotech

    IBD
  3. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  4. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga
  5. Treasury Develolping Options to Curb Inversions

    FoxBusiness
  6. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  7. Pfizer Announces Submission of Palbociclib New Drug Application To The ...

    Benzinga
  8. Pfizer Announces FDA Acceptance Of And Priority Review Designation For ...

    Benzinga
  9. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  10. Buyback Mania Inflates 2Q Earnings Growth

    FoxBusiness
  11. YCharts Research: August 2014 Valuation Snapshot

    YCharts
  12. Pfizer Issues Top-Line Results from Potherpetic Neuralgia, Painful Diabetic ...

    Benzinga
  13. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  14. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  15. Legendary Investor Irving Kahn's Top Five Stocks

    GuruFocus
  16. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  17. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  18. Drugmaker AstraZeneca Returns To Growth

    IBD
  19. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  20. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  21. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  22. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  23. The Stocks Already in Correction Mode

    FoxBusiness
  24. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus
  25. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  26. Amgen To Slash Workforce

    IBD
  27. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  28. Pharmaceutical ETFs Are Health Care Sector Standouts

    Benzinga
  29. Tuesday Morning Earnings Releases

    Benzinga
  30. Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition

    Benzinga
  31. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD
  32. Stocks Climb In Early Trade; Herbalife, El Pollo Loco Dive

    IBD
  33. UPDATE: Pfizer Posts Upbeat Q2 Results, Shares Gain

    Benzinga
  34. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating Nuclear ...

    Benzinga
  35. Earnings Scheduled For July 29, 2014

    Benzinga
  36. Stocks To Watch For July 29, 2014

    Benzinga
  37. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  38. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  39. UPDATE: BMO Capital Downgrades Pfizer

    Benzinga
  40. Benzinga's Top Downgrades

    Benzinga
  41. BMO Capital Downgrades Pfizer To Market Perform, Shares Drop

    Benzinga
  42. Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And ...

    Benzinga
  43. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  44. Week Ahead: July Jobs Report, FOMC and GDP

    FoxBusiness
  45. Diamond Hill Capital Comments on Pfizer Inc

    GuruFocus
  46. BlackRock: Stocks Iffy, But Not These Pockets

    YCharts
  47. Obama Aims at 'Unpatriotic' Corporate Inversions

    FoxBusiness
  48. Dodge & Cox Second Quarter 2014 Commentary

    GuruFocus
  49. Pfizer: A Fairly Valued Stock

    GuruFocus
  50. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
Trading Center